Bone turnover disorders, including osteoporosis, osteomalacia, Paget’s disease, CKD–mineral bone disorder, and treatment-related skeletal changes, require paired assessment of bone formation and resorption to guide therapy and monitor response. At Southern Medical Supplies Limited (SMSL), we provide comprehensive panels covering formation markers (P1NP, bone-specific alkaline phosphatase, osteocalcin) and resorption markers (serum CTX-I, urinary NTx, TRACP-5b), alongside the mineral–hormonal axis (total and ionized calcium, phosphate, magnesium, albumin, intact PTH, 25-OH vitamin D with reflex 1,25-(OH)₂D), adjuncts such as FGF23 for hypophosphatemic states, and urine Ca/Cr or 24-hour calcium/phosphate with renal indices (creatinine/eGFR). Our solutions span ELISA, chemiluminescent immunoassay, clinical chemistry, and molecular platforms sourced from a broad network of global partners—EUROIMMUN, Ansh Labs, Randox, Streck, Bio-Rad, Abbott, Roche, Siemens Healthineers, Qiagen, bioMérieux, Cepheid, Werfen, Globe Scientific, ELGA LabWater, LW Scientific, Sebia, LTA SRL, Acrobiotech, MAKOL Innovacion Medica, Rayto Life and Analytical Sciences, Diazyme, Hardy’s Diagnostics, and Teco Diagnostics—delivering the accuracy, sensitivity, and reproducibility needed to identify etiology, personalize therapy, and track outcomes in bone turnover disorders.